Quick Summary
The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals Fertilizers, Department of Pharmaceuticals, has issued an Office Memorandum (F. No. 12(24)/2021/1DP/NFPA/Div.II(Vol.II)-Part(1)) mandating the implementation of revised Maximum Retail Prices (MRPs) for medicines, formulations, and medical devices, effective from 22nd September 2025, in light of the recent Goods and Services Tax (GST) rate rationalisation announced during the 56th GST Council meeting. Key Hi
Daily Limit Reached
You have reached your daily limit of 2 Free News
Subscribe to CCI PRO for unlimited access
Why Upgrade to CCI PRO?
- No Ads
- WhatsApp Community
- Daily E-Newsletter
- Unlimited News Access
- Profile Visitors
- Link Social Profiles
- Featured Job Posts
- Pro Badge
- Expert GST Guidance
- Unlimited Forum Replies
- Download Content in PDF
1 Year PLAN
1999
(Excl. of GST ₹359)
BEST VALUE
2 Years PLAN
3499
(Excl. of GST ₹629)
3 Months PLAN
999
(Excl. of GST ₹179)
View all CCI PRO benefits
Already a PRO member? Login here for an ad-free experience.
FAQ :
The NPPA has directed drug manufacturers and marketing companies to pass on the benefits of reduced GST rates to consumers by revising the Maximum Retail Prices (MRPs) of medicines and medical devices.
The revised MRPs, reflecting the reduced GST rates, will be effective from 22nd September 2025.
No, it is not mandatory to re-label or re-sticker products already in the market before 22nd September 2025, provided the revised MRPs are publicly communicated.
Manufacturers are directed to use all communication channels, including print, electronic, and social media, to inform dealers, retailers, and consumers about the revised GST rates and MRPs.
Industry associations are encouraged to release advertisements in leading national and vernacular newspapers to inform dealers and retailers about the revised GST rates and ensure compliance.
Yes, manufacturers can opt for phased re-labelling or re-stickering of stock, provided it does not lead to shortages of drugs or medical devices.
CAclubindia
